3
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Once-daily medications for the pharmacological management of ADHD in adults

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Attention-deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed psychiatric disorder in children and adolescents. Symptoms of ADHD often persist beyond childhood and present significant challenges to adults. Pharmacotherapy is a first-line treatment option for ADHD across all age groups. The current review’s goals are (a) to critically examine the current state of knowledge regarding once-daily formulations of pharmacotherapies for treatment of adults with ADHD and (b) to provide clinicians with evidence-based information regarding the safety, efficacy and tolerability of once-daily medications for adult ADHD. The reviewed body of evidence strongly supports the use of pharmacotherapy as a first-line therapeutic option for the treatment of adults with ADHD. The once-daily pharmacological agents are effective therapeutic options for the treatment of adults with ADHD. In the US, based on the available evidence, once-daily medications are currently underutilized in adults with ADHD compared to pediatric population.

          Related collections

          Author and article information

          Journal
          Ther Clin Risk Manag
          Therapeutics and Clinical Risk Management
          Therapeutics and Clinical Risk Management
          Dove Medical Press
          1176-6336
          1178-203X
          2009
          2009
          20 May 2009
          : 5
          : 367-379
          Affiliations
          [1 ]Department of Psychiatry, Behavioral Health Center – Carolinas Medical Center, Charlotte, NC, USA;
          [2 ]Carolinas College of Health Sciences, Charlotte, NC, USA
          Author notes
          Correspondence: Oleg V Tcheremissine, Department of Psychiatry, CMC-Behavioral Health Center, 501 Billingsley Road, Charlotte, North Carolina, 28211, USA, Tel +1 704 446 7504, Fax +1 704 446 7505, Email oleg.tcheremissine@ 123456carolinas.org
          Article
          tcrm-5-367
          2697545
          19536322
          © 2009 Tcheremissine and Lieving, publisher and licensee Dove Medical Press Ltd.

          This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.

          Categories
          Review

          Medicine

          adults, attention deficit/hyperactivity disorder, once-daily pharmacotherapies

          Comments

          Comment on this article